21
GNI Group
2160.T·TSETokyo JPFounded 2001800 employees
Small CapbiotechPublicPulmonologyHepatology
Platform: Pirfenidone Fibrosis
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (2160.T)
Loading 2160.T stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Motanaritide | 216-5513 | Approved | 2 | B7-H3 | PNHRB | ||
| Datozumab | 216-6642 | Phase 1/2 | 1 | PCSK9 | Alzheimer'sCRC |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
GNI Group trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)